At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 84 enrolled
Drug / intervention
Ropivacaine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Local Anesthetic Wound Infiltration on Postoperative Pain Following Cesarean Delivery
In Brief
A Phase 4 clinical trial evaluating Ropivacaine, Ketorolac, and 1 other intervention for Pain. Completed, enrolled 84 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if the infusion of the local anesthetic ropivacaine (a numbing medicine) and the non-steroidal anti-inflammatory drug ketorolac (a pain killer similar to ibuprofen) through a catheter placed along the cesarean delivery incision, will reduce the pain experienced after cesarean section and need for narcotic pain medicine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedJul 2016
Enrollment StartNov 2016
Primary CompletionMar 2019
Study CompletionSep 2019
TodayJul 2026
First PostedJul 12, 2016
Enrollment StartNov 1, 2016
Primary CompletionMar 1, 2019
Study CompletionSep 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 10.0 years ago
Interventions
Ropivacainedrug
Ketorolacdrug
Placebodrug